Cargando…

Rituximab: A viable treatment option for epoetin-induced pure red cell aplasia

Pure red cell aplasia (PRCA) due to neutralizing antibodies can rarely develop following treatment with epoetin. The treatment of this condition is generally unsatisfactory and immunosuppression is often recommended, which improves chances of hematological recovery. We describe a case of PRCA due to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahajan, S. A., Nandagopal, N., Soni, M., Annigeri, R. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663775/ https://www.ncbi.nlm.nih.gov/pubmed/26664213 http://dx.doi.org/10.4103/0971-4065.156897

Ejemplares similares

Pure red cell aplasia induced by epoetin zeta
por: Panichi, Vincenzo, et al.
Publicado: (2016)

Rituximab therapy for pure red cell aplasia due to anti-epoetin antibodies in a woman treated with epoetin-alfa: a case report
por: Behler, Caroline M, et al.
Publicado: (2009)

Pure red cell aplasia after treatment of renal anaemia with epoetin theta
por: Herrington, W., et al.
Publicado: (2013)

Resolution of epoetin‐induced pure red cell aplasia, successful re‐challenge with roxadustat
por: Wu, Yunzhou, et al.
Publicado: (2020)

Antibody-mediated pure red cell aplasia (PRCA) on switching from darbepoetin alfa to epoetin beta: what are the implications?
por: Assunção, José, et al.
Publicado: (2008)

Emtricitabine-induced pure red cell aplasia
por: Manickchund, Nithendra, et al.
Publicado: (2019)

Zidovudine-induced reversible pure red cell aplasia
por: Balakrishnan, Anuja, et al.
Publicado: (2010)

Myelodysplastic Syndrome with Erythroid Aplasia following Pure Red Cell Aplasia
por: Kim, Hyoung Doo, et al.
Publicado: (2004)

Primary acquired chronic pure red cell aplasia refractory to standard treatments: remission with rituximab
por: Tendas, Andrea, et al.
Publicado: (2016)

Pure red cell aplasia and associated thymoma
por: Rosu, Cristian, et al.
Publicado: (2011)

Lenalidomide-Induced Pure Red Cell Aplasia
por: Dolai, Tuphan Kanti, et al.
Publicado: (2014)

Erythropoietin‐induced pure red cell aplasia
por: Yeung, Vivian K. P.
Publicado: (2022)

Case Report: Roxadustat in Combination With Rituximab Was Used to Treat EPO-Induced Pure Red Cell Aplasia
por: You, Xiaoe, et al.
Publicado: (2022)

Pure red cell aplasia as first manifestation of splenic marginal zone lymphoma-successful treatment with rituximab: a case report
por: Anastasiadis, Athanasios, et al.
Publicado: (2009)

Antibody-mediated pure red cell aplasia related with epoetin-beta pegol (C.E.R.A.) as an erythropoietic agent: case report of a dialysis patient
por: Shingu, Yasuki, et al.
Publicado: (2020)

Thymoma associated with hypogammaglobulinaemia and pure red cell aplasia
por: Briones, Juan, et al.
Publicado: (2013)

Pure Red Cell Aplasia Associated with Good Syndrome
por: Okui, Masayuki, et al.
Publicado: (2017)

TKI-induced pure red cell aplasia: first case report of pure red cell aplasia with both imatinib and nilotinib
por: Poudyal, Bishesh Sharma, et al.
Publicado: (2016)

Linezolid-Induced Pure Red Cell Aplasia: A Case Report
por: Yang, Xiao-Yan, et al.
Publicado: (2022)

Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasia
por: Gangat, Naseema, et al.
Publicado: (2022)

Isoniazid Induced Pure Red Blood Cell Aplasia
por: Azhar, Waqas, et al.
Publicado: (2020)

Pure Red Cell Aplasia Caused by Acute Hepatitis A
por: Lee, Tae Heon, et al.
Publicado: (2011)

Pure Red Cell Aplasia Following Interleukin-2 Therapy
por: Dutcher, Janice P., et al.
Publicado: (2016)

Pure Red Cell Aplasia with Adult Onset Still's Disease
por: Robillard, Nicholas, et al.
Publicado: (2013)

Invasive Thymoma with Pure Red Cell Aplasia and Amegakaryocytic Thrombocytopenia
por: Onuki, Takuya, et al.
Publicado: (2016)

Acquired Amegakaryocytic Thrombocytopenia and Pure Red Cell Aplasia in Thymoma
por: Dahal, Sumit, et al.
Publicado: (2018)

Aggressive Systemic Mastocytosis in Association with Pure Red Cell Aplasia
por: Karam, Dhauna, et al.
Publicado: (2018)

Pembrolizumab-induced Pure Red Cell Aplasia Successfully Treated with Intravenous Immunoglobulin
por: Isoda, Atsushi, et al.
Publicado: (2020)

Durvalumab-Induced Secondary Pure Red Cell Aplasia Successfully Treated With Cyclosporin
por: Watanabe, Kageaki, et al.
Publicado: (2020)

Pure Red Cell Aplasia with Del(20q) Sensitive for Immunosuppressive Treatment
por: Vo, Anh Khoi, et al.
Publicado: (2020)

Pure Red Cell Aplasia Associated With Thymoma
por: Thangatorai, Ramesh
Publicado: (2023)

Acquired pure red cell aplasia: updated review of treatment
por: Sawada, Kenichi, et al.
Publicado: (2008)

Rituximab is highly effective for pure red cell aplasia and post-transplant lymphoproliferative disorder after unrelated hematopoietic stem cell transplantation
por: Kopińska, Anna, et al.
Publicado: (2012)

Pure red cell aplasia and seronegative myasthenia gravis in association with thymoma
por: Lee, Sun Yong, et al.
Publicado: (2020)

Pure red cell aplasia and amegakaryocytic thrombocytopenia in thymoma: The uncharted territory
por: Dragani, Matteo, et al.
Publicado: (2020)

A pregnant woman with thymoma-associated pure red cell aplasia
por: Shibata, Megumi, et al.
Publicado: (2022)

Hepatitis C Infection Associated with Acquired Pure Red Cell Aplasia
por: Teague, Destini, et al.
Publicado: (2022)

Linezolid-induced pure red cell aplasia: a case report and literature review
por: Luo, Zhuanbo, et al.
Publicado: (2018)

A case series of emtricitabine-induced pure red cell aplasia
por: Manickchund, Nithendra, et al.
Publicado: (2021)

Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation
por: Jung, Sung-Hoon, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_r59hjbjt9f80v4d32rl0tk45p6